Home
Bioprocessing
Chromatography
Drug Delivery
Excipients
Formulation Development
Microbiology
Spectroscopy
Articles
Issue Archives
Whitepapers / App Notes / eBooks
Infographics
Facility Tour
CGT Circuit
News
Industry News
Supplier News
All News
Products
Featured Products
New Products
Analytical Equipment
Formulation Development
Pharmaceutical Manufacturing
Excipients
All Other Products
QC Corner
Webinars
Videos
Documentaries
Company Profiles
Events
Register
Sign In
Welcome Guest
Sign In
Register
The presence and persistence of ERCC-1 positive circulating tumor cells predicts worse prognosis in primary ovarian cancer patients
The presence and persistence of ERCC-1 positive circulating tumor cells predicts worse prognosis in primary ovarian cancer patients
Monday, May 23, 2016
Tweet
Transcript
Embed
Email
Bookmark
Chapters
Introduction
Resistance to platinum-based chemotherapy
Background
Patients and Methods
Results
Capacity of Circulating Tumor Cells
Technologies in Liquid Biopsy
Bioinformatics Tool
Results
Plans for the Future
CTC’s in Screening?
Conclusion
No transcript for this webinar
More Information
Contact Us
Videos
On-Demand Webinar: Establishing a Facility Isolate...
Wednesday, January 22, 2025
Improve Your Microbial QC Testing Efficiency
Tuesday, January 14, 2025
Cell and Gene Therapy Analytical Testing ...
Monday, December 30, 2024
Watch Video: Partnerships to Promote ...
Friday, November 15, 2024
Watch Video: How Modern Methods Help Reduce Time ...
Friday, November 15, 2024
Watch Video: How Charles River Uses Pharma 4.0
Friday, November 15, 2024
Analytical Testing Regulatory Requirements for ...
Thursday, November 07, 2024
Lab Balances in QC Labs
Monday, November 04, 2024
Moving Towards Sustainable BET Testing
Monday, October 14, 2024
Live Webinar: Understanding the Invisible Threat: ...
Thursday, October 10, 2024
Co-Processed Excipients for Self-Emulsifying Drug ...
Monday, September 09, 2024
Ensuring Regulatory Compliance in Cell Therapies ...
Tuesday, September 03, 2024
On-Demand Webinar: Analytical Considerations for ...
Wednesday, July 24, 2024
Optimizing Lipid Nanoparticles (LNPs) Processing ...
Monday, July 15, 2024
On-Demand Webinar: Optimizing Endotoxin Testing ...
Thursday, June 13, 2024
Page
<<
<
1
2
3
4
>
>>